文献速递新发突发、热带与寄生虫病医院感染防控

寨卡病毒暴发研究应对中的障碍仍未解决

Familiar barriers still unresolved-a perspective on the Zika virus outbreak research response.
PubMed 文献 · Lancet Infect Dis · 2018-11-09

欧盟资助的ZIKAlliance联盟开展多国流行病学、临床和实验室研究,旨在确定孕妇及其子女寨卡病毒感染的发病率、危险因素和结局。研究回顾了患者队列启动时间线,并通过系统电话访谈评估障碍,识别出资金流程无时间表、监管伦理审批延迟和实验室支持物流困难三大瓶颈。

要点

  • 寨卡暴发研究应对存在资金流程无时间表、监管伦理审批延迟和实验室支持物流困难三大瓶颈
  • 需要建立永久性全球新发传染病研究能力,具备结构化资金和可部署的响应基础设施
  • 长期合作伙伴关系和基础临床与实验室研究是快速研究应对的关键

核心结论

  • 实施快速研究应对存在三大瓶颈:资金流程无时间表、监管伦理审批延迟和实验室支持物流困难。
  • 迫切需要在全球范围内建立强大且永久的新发传染病研究能力。

研究设计与样本

  • 欧盟资助的ZIKAlliance联盟开展多国流行病学、临床和实验室研究。
  • 回顾患者队列启动时间线,并通过系统电话访谈评估国际研究团队经历的障碍和延迟。

主要发现

  • 识别出三个主要瓶颈:资金流程无时间表、监管和伦理审批延迟、实验室支持(包括诊断)的物流困难。

临床怎么用

  • 需要结构化资金、长期合作伙伴关系以及可随时部署的基础临床和实验室研究响应基础设施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Research is an important component of an effective response to the increasing frequency of widespread infectious disease outbreaks. In turn, the ability to do such studies relies on willingness of partners in different regions to collaborate and the capacity to mount a rapid research response. The EU-funded ZIKAlliance Consortium has initiated a multicountry epidemiological, clinical, and laboratory research agenda to determine the incidence, risk factors, and outcomes of Zika virus infection in pregnant women and their children. We reviewed the timeline of patient cohort initiation in relation to the Zika virus epidemic and mapped key events regarding funding, regulatory approvals, and site preparation during this timeline. We then assessed barriers and delays that the international research team experienced through a systematic telephone interview. We have identified three major bottlenecks in the implementation of a swift response: the absence of a timeline for the funding process, delays in regulatory and ethical approval, and the challenging logistics of laboratory support, including diagnostics. These bottlenecks illustrate the clear and urgent need for implementing a strong and permanent global emerging infectious diseases research capacity that has structured funding, enables long-term partnerships, and develops basic clinical and laboratorial research and a response infrastructure that is ready to deploy.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Koopmans M, de Lamballerie X, Jaenisch T, et al. Familiar barriers still unresolved-a perspective on the Zika virus outbreak research response. Lancet Infect Dis. 2018. PMID: 30420230. doi:10.1016/S1473-3099(18)30497-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。